Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
CHU Brugmann, Brussels, Belgium
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Demikhov Municipal Clinical Hospital 68, Moscow, Russian Federation
Yongming Chen, Shanghai, Shanghai, China
Mansoura University, Mansoura, DK, Egypt
Henan Provincial People's Hospital, Zhengzhou, Henan, China
Showa Inan General hospital, Komagane, Nagano, Japan
Peking University First Hospital, Beijing, China
Ajou University Hospital, Suwon, Gyeonggi-do, Korea, Republic of
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.